{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:53:56Z","timestamp":1777870436719,"version":"3.51.4"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-025-02286-6","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T06:41:09Z","timestamp":1750315269000},"page":"1639-1646","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Performance of the Kidney Failure Risk Equation according to diabetic status in the CKD-CAREMEAU cohort of patients with chronic kidney disease"],"prefix":"10.1093","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5944-5598","authenticated-orcid":false,"given":"Julien","family":"Prouvot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Reboul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedram","family":"Ahmadpoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edouard","family":"Clemmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Gerbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Garo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Cariou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Pambrun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyad","family":"Messikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3127-1415","authenticated-orcid":false,"given":"Olivier","family":"Moranne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"key":"2286_CR1","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","volume":"298","author":"J Coresh","year":"2007","unstructured":"Coresh J, Selvin E, Stevens LA et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 298:2038\u20132047. https:\/\/doi.org\/10.1001\/jama.298.17.2038","journal-title":"JAMA"},{"key":"2286_CR2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1172\/JCI27699","volume":"116","author":"G Remuzzi","year":"2006","unstructured":"Remuzzi G, Benigni A, Remuzzi A (2006) Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 116:288\u2013296. https:\/\/doi.org\/10.1172\/JCI27699","journal-title":"J Clin Invest"},{"key":"2286_CR3","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1093\/ndt\/gfaa155","volume":"36","author":"MHC van Rijn","year":"2021","unstructured":"van Rijn MHC, van de Luijtgaarden M, van Zuilen AD et al (2021) Prognostic models for chronic kidney disease: a systematic review and external validation. Nephrol Dial Transplant 36:1837\u20131850. https:\/\/doi.org\/10.1093\/ndt\/gfaa155","journal-title":"Nephrol Dial Transplant"},{"key":"2286_CR4","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s40620-021-01180-1","volume":"35","author":"J Prouvot","year":"2022","unstructured":"Prouvot J, Pambrun E, Antoine V et al (2022) Low performance of prognostic tools for predicting death before dialysis in older patients with advanced CKD. J Nephrol 35:993\u20131004. https:\/\/doi.org\/10.1007\/s40620-021-01180-1","journal-title":"J Nephrol"},{"key":"2286_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1001\/jama.2015.18202","volume":"315","author":"N Tangri","year":"2016","unstructured":"Tangri N, Grams ME, Levey AS et al (2016) Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis. JAMA 315:164\u2013174. https:\/\/doi.org\/10.1001\/jama.2015.18202","journal-title":"JAMA"},{"key":"2286_CR6","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1001\/jama.2011.451","volume":"305","author":"N Tangri","year":"2011","unstructured":"Tangri N, Stevens LA, Griffith J et al (2011) A Predictive model for progression of chronic kidney disease to kidney failure. JAMA 305:1553\u20131559. https:\/\/doi.org\/10.1001\/jama.2011.451","journal-title":"JAMA"},{"key":"2286_CR7","unstructured":"(2021) Recommendations | Chronic kidney disease: assessment and management | Guidance | NICE. https:\/\/www.nice.org.uk\/guidance\/ng203\/chapter\/Recommendations#risk-assessment-referral-criteria-and-shared-care. Accessed 17 Apr 2023"},{"key":"2286_CR8","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s40620-021-01204-w","volume":"35","author":"C Schulz","year":"2022","unstructured":"Schulz C, Messikh Z, Reboul P et al (2022) Characteristics of outpatients referred for a first consultation with a nephrologist: impact of different guidelines. J Nephrol 35:1375\u20131385. https:\/\/doi.org\/10.1007\/s40620-021-01204-w","journal-title":"J Nephrol"},{"key":"2286_CR9","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"PE Stevens","year":"2024","unstructured":"Stevens PE, Ahmed SB, Carrero JJ et al (2024) KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 105:S117\u2013S314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018","journal-title":"Kidney Int"},{"key":"2286_CR10","unstructured":"HAS (2023) Guide du parcours de soins \u2013 Maladie r\u00e9nale chronique de l\u2019adulte (MRC)"},{"key":"2286_CR11","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s40620-020-00919-6","volume":"34","author":"J Prouvot","year":"2021","unstructured":"Prouvot J, Pambrun E, Couchoud C et al (2021) Low performance of prognostic tools for predicting dialysis in elderly people with advanced CKD. J Nephrol 34:1201\u20131213. https:\/\/doi.org\/10.1007\/s40620-020-00919-6","journal-title":"J Nephrol"},{"key":"2286_CR12","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1016\/j.ekir.2021.09.006","volume":"6","author":"GL Hundemer","year":"2021","unstructured":"Hundemer GL, Tangri N, Sood MM et al (2021) The effect of age on performance of the Kidney Failure Risk Equation in advanced CKD. Kidney International Reports 6:2993\u20133001. https:\/\/doi.org\/10.1016\/j.ekir.2021.09.006","journal-title":"Kidney International Reports"},{"key":"2286_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyab256","author":"CL Ramspek","year":"2021","unstructured":"Ramspek CL, Teece L, Snell KIE et al (2021) Lessons learnt when accounting for competing events in the external validation of time-to-event prognostic models. Int J Epidemiol. https:\/\/doi.org\/10.1093\/ije\/dyab256","journal-title":"Int J Epidemiol"},{"key":"2286_CR14","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1681\/ASN.2019060640","volume":"30","author":"P Ravani","year":"2019","unstructured":"Ravani P, Fiocco M, Liu P et al (2019) Influence of Mortality on Estimating the Risk of Kidney Failure in People with Stage 4 CKD. JASN 30:2219\u20132227. https:\/\/doi.org\/10.1681\/ASN.2019060640","journal-title":"JASN"},{"key":"2286_CR15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12882-021-02402-1","volume":"22","author":"I Ali","year":"2021","unstructured":"Ali I, Donne RL, Kalra PA (2021) A validation study of the Kidney Failure Risk Equation in advanced chronic kidney disease according to disease aetiology with evaluation of discrimination, calibration and clinical utility. BMC Nephrol 22:194. https:\/\/doi.org\/10.1186\/s12882-021-02402-1","journal-title":"BMC Nephrol"},{"key":"2286_CR16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.kint.2017.01.030","volume":"92","author":"CP Wen","year":"2017","unstructured":"Wen CP, Chang CH, Tsai MK et al (2017) Diabetes with early kidney involvement may shorten life expectancy by 16 years. Kidney Int 92:388\u2013396. https:\/\/doi.org\/10.1016\/j.kint.2017.01.030","journal-title":"Kidney Int"},{"key":"2286_CR17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1053\/j.ackd.2017.10.011","volume":"25","author":"DN Koye","year":"2018","unstructured":"Koye DN, Magliano DJ, Nelson RG, Pavkov ME (2018) The global epidemiology of diabetes and kidney disease. Adv Chronic Kidney Dis 25:121\u2013132. https:\/\/doi.org\/10.1053\/j.ackd.2017.10.011","journal-title":"Adv Chronic Kidney Dis"},{"key":"2286_CR18","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.2215\/CJN.03940320","volume":"15","author":"GL Hundemer","year":"2020","unstructured":"Hundemer GL, Tangri N, Sood MM et al (2020) Performance of the Kidney Failure Risk Equation by disease etiology in advanced CKD. CJASN 15:1424\u20131432. https:\/\/doi.org\/10.2215\/CJN.03940320","journal-title":"CJASN"},{"key":"2286_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190930","volume":"13","author":"M Yamanouchi","year":"2018","unstructured":"Yamanouchi M, Hoshino J, Ubara Y et al (2018) Value of adding the renal pathological score to the Kidney Failure Risk Equation in advanced diabetic nephropathy. PLoS ONE 13:e0190930. https:\/\/doi.org\/10.1371\/journal.pone.0190930","journal-title":"PLoS ONE"},{"key":"2286_CR20","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604\u2013612. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006","journal-title":"Ann Intern Med"},{"key":"2286_CR21","unstructured":"Agence de la Biom\u00e9decine (2019) Rapport REIN 2019"},{"key":"2286_CR22","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.2337\/dci20-0022","volume":"43","author":"WK Chung","year":"2020","unstructured":"Chung WK, Erion K, Florez JC et al (2020) Precision medicine in diabetes: a consensus report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 43:1617\u20131635. https:\/\/doi.org\/10.2337\/dci20-0022","journal-title":"Diabetes Care"},{"key":"2286_CR23","unstructured":"Buuren S van, Groothuis-Oudshoorn K, Vink G, et al (2022) mice: Multivariate Imputation by Chained Equations"},{"key":"2286_CR24","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.143.1.7063747","author":"JA Hanley","year":"1982","unstructured":"Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. https:\/\/doi.org\/10.1148\/radiology.143.1.7063747","journal-title":"Radiology"},{"key":"2286_CR25","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837\u2013845. https:\/\/doi.org\/10.2307\/2531595","journal-title":"Biometrics"},{"key":"2286_CR26","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M14-0698","volume":"162","author":"KGM Moons","year":"2015","unstructured":"Moons KGM, Altman DG, Reitsma JB et al (2015) Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration. Ann Intern Med 162:W1\u2013W73. https:\/\/doi.org\/10.7326\/M14-0698","journal-title":"Ann Intern Med"},{"key":"2286_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-024-03649-9","volume":"22","author":"H Walker","year":"2024","unstructured":"Walker H, Day S, Grant CH et al (2024) Representation of multimorbidity and frailty in the development and validation of kidney failure prognostic prediction models: a systematic review. BMC Med 22:1\u201315. https:\/\/doi.org\/10.1186\/s12916-024-03649-9","journal-title":"BMC Med"},{"key":"2286_CR28","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/ndt\/gfu294","volume":"30","author":"S Titze","year":"2015","unstructured":"Titze S, Schmid M, Kottgen A et al (2015) Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort. Nephrol Dial Transplant 30:441\u2013451. https:\/\/doi.org\/10.1093\/ndt\/gfu294","journal-title":"Nephrol Dial Transplant"},{"key":"2286_CR29","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.nephro.2021.06.008","volume":"17","author":"N Alencar de Pinho","year":"2021","unstructured":"Alencar de Pinho N, Capgras J-B, Speyer \u00c9 et al (2021) R\u00e9alit\u00e9 de la prise en charge de la maladie r\u00e9nale chronique en n\u00e9phrologie en France\u202f: \u00e9tude de cohorte CKD-REIN. Nephrol Ther 17:496\u2013506. https:\/\/doi.org\/10.1016\/j.nephro.2021.06.008","journal-title":"Nephrol Ther"},{"key":"2286_CR30","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/ki.2012.174","volume":"82","author":"LD Nicola","year":"2012","unstructured":"Nicola LD, Minutolo R, Chiodini P et al (2012) The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care. Kidney Int 82:482\u2013488. https:\/\/doi.org\/10.1038\/ki.2012.174","journal-title":"Kidney Int"},{"key":"2286_CR31","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.1002\/sim.9025","volume":"40","author":"RD Riley","year":"2021","unstructured":"Riley RD, Debray TPA, Collins GS et al (2021) Minimum sample size for external validation of a clinical prediction model with a binary outcome. Stat Med 40:4230\u20134251. https:\/\/doi.org\/10.1002\/sim.9025","journal-title":"Stat Med"},{"key":"2286_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2021.10.008","author":"J Zee","year":"2022","unstructured":"Zee J, Muenz D, McCullough KP et al (2022) Potential surrogate outcomes for kidney failure in advanced CKD: evaluation of power and predictive ability in CKDopps. Kidney Medicine. https:\/\/doi.org\/10.1016\/j.xkme.2021.10.008","journal-title":"Kidney Medicine"},{"key":"2286_CR33","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1515\/cclm-2022-0049","volume":"60","author":"G R\u00e9simont","year":"2022","unstructured":"R\u00e9simont G, Vranken L, Pottel H et al (2022) Estimating urine albumin to creatinine ratio from protein to creatinine ratio using same day measurement: validation of equations. Clinical Chemistry and Laboratory Medicine (CCLM) 60:1064\u20131072. https:\/\/doi.org\/10.1515\/cclm-2022-0049","journal-title":"Clinical Chemistry and Laboratory Medicine (CCLM)"},{"key":"2286_CR34","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1515\/cclm-2022-0928","volume":"61","author":"P Delanaye","year":"2023","unstructured":"Delanaye P, Schaeffner E, Cozzolino M et al (2023) The new, race-free, Chronic Kidney Disease Epidemiology Consortium (CKD-EPI) equation to estimate glomerular filtration rate: is it applicable in Europe? A position statement by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). Clinical Chemistry and Laboratory Medicine (CCLM) 61:44\u201347. https:\/\/doi.org\/10.1515\/cclm-2022-0928","journal-title":"Clinical Chemistry and Laboratory Medicine (CCLM)"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-025-02286-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-025-02286-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-025-02286-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:59:31Z","timestamp":1777564771000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/38\/6\/1639\/8457514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["2286"],"URL":"https:\/\/doi.org\/10.1007\/s40620-025-02286-6","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"assertion":[{"value":"2 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicting interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval This study was performed in line with the principles of the Declaration of Helsinki and was approved by the ethical committee of N\u00eemes University Hospital under the IRB number 24.02.02.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Patients were informed of the study by letter and were included if they were unopposed to the use of their data from electronic records.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}